This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The advent of biologic therapies in the 1970s along with the decoding of the human genome in 2003 heralded an explosion in pharmaceutical innovation. The evidence‑generation process has become far more challenging.
And this is where modern technologies and data-driven medical informatics can really bridge the gaps in rare disease research,” said Dr Joanne Hackett, head of Genomic and Precision Medicine at IQVIA, during a recent pharmaphorum webinar. Navigating rare disease research and treatment.
The Human Genome Project could not have succeeded without the use of bioinformatics. Specific skills are required to succeed in this job; these include advanced writing skills for scientific literature, developing software tools, working on genome sequencing projects, and designing DNA sequencing libraries.
By leveraging data from genomic studies and electronic health records, marketers can identify niche markets and craft messages that speak directly to the needs and concerns of specific patient populations. One major area of regulatory change is the emphasis on patient data protection.
The collected data and the genomic studies can play a crucial role in monitoring the symptoms and predicting potential diseases. . The safety of patients’ data is always a vital issue in the healthcare industry. Cybersecurity in Healthcare. Healthcare Mobile Apps (Medical mobile applications).
Longwood has a robust research department with 7 post doctorates conducting research in molecular biology, microbiology, genomics, cancer biology, and immunology and publishing over 75 publications in different scientific journals in the past 5 years.
relevant government policies and regulations relating to our industry.
It’s a statistical model, which by design, guarantees confidentiality and satisfies the requirements of Hospital ethics committees, NHS regulations and Life Science industry policies. AI use in the pandemic. With AI technologies emerging as key tools to address the pandemic, health research is seeing a huge technological revolution. “We’ve
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content